| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |